PRIYANKA SHANBHAG

A proficient individual with experience in market access, pricing & reimbursement strategies, market research, and project management. Proficient knowledge of designing and evaluating questionnaires, pricing, and reimbursement assessment methodologies, for economic & clinical evaluations. Experience in conducting quantitative and qualitative payer, physicians, pharmacists, and patient studies. Experience in systematic literature reviews, gap assessments, development of manuscripts, posters, and presentations. Support development of budget impact model, triangulation model and cost of care model. Proficient knowledge of economics analysis such as cost effectiveness analysis (CEA), cost benefit analyses (CBA) and cost utility analyses (CUA) and Markov model. Skills in maintaining strategic relationships with internal and external decision makers. Ability to consistently meet deadlines in a cross-functional, and dynamic environment.

• Status of Current Outcomes-Based Contracting Approaches and Future Thoughts' at Academy of Managed Care Pharmacy (AMCP) Nexus, 2017.
• Prevalence of adult ADHD and Non-Medical Use of Stimulants' at MBAA International Conference, 2015
• Exploring the Impact of an Academic Course on Students' Knowledge, Learning and Attitudes toward Managed Care Pharmacy' at Academy of Managed Care Pharmacy (AMCP) Nexus, 2016.
• Prevalence of Self-Reported Adult ADHD Symptoms Among University Students' at ISPOR, 2015
• Off-label Prescribing and Polytherapy of Atypical Antipsychotics: A Double Whammy for Dementia Residents in Nursing Homes? ISPOR, 2014
• Are Promotional Strategies of Lifestyle Drugs Different from Non-Lifestyle Drugs?' at ISPOR, 2014
• Use of Product Life Cycle (PLC) to Understand Advertising Strategies Used by Pharmaceutical Companies' at ISPOR, 2014
• Impact of Satisfaction and Service Quality on Customer Loyalty' at APhA Annual Meeting, 2015

• National & State Poster and Working Model Finalist Award 'Novel Strategy for administering drugs to patients combating a 'Royal Disease-Hemophilia' at Pharmazeal, India, 2012.
• State Poster Finalist Award 'Novel Formulation for Atherosclerosis' at Indian Pharmaceutical Association, India, 2011.